#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Epilepsy with myoclonic-atonic seizures Microvillous inclusion disease Cystic fibrosis lung Henoch-Schonlein purpura nephritis Phenylketonuria Prolymphocytic leukaemia Hepatitis D Metastases to peritoneum Antisynthetase syndrome Brain abscess Nasopharyngeal cancer Biliary cancer metastatic Sickle cell disease Ventricular tachycardia Sarcoidosis More trials…

    Learn about Rare Diseases

    Paroxysmal nocturnal haemoglobinuria – Treatment Malignant fibrous histiocytoma Progressive multifocal leukoencephalopathy – Treatment Krabbe’s disease – Treatment Alport’s syndrome Hereditary hypophosphataemic rickets Sarcoidosis – Trials in Disease Paroxysmal nocturnal haemoglobinuria – Basic Information Mucopolysaccharidosis – Life with Disease Chondrosarcoma metastatic More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lna043 Azd2693 Sodium Morf-057 Regn9933 Levosimendan Cart 19/22 T Cells LUNRESERTIB Icatibant Tazemetostat Tazobactam Metoclopramide Imidapril Hydrochloride MB-HUCART19.1 Doxorubicin Hydrochloride Charcoal, Activated Sacubitril Volrustomig Varnimcabtagene Autoleucel Sitravatinib Malate Auto4 More therapies…

    Learn about Your Condition

    Breast cancer male Nodular melanoma Ewing's sarcoma metastatic Arrhythmia Noninfective chorioretinitis Rectal cancer Inguinal hernia Reperfusion injury Tricuspid valve disease Peripheral artery angioplasty Bacterial vaginosis Ligament operation Primary hyperthyroidism Endometrial cancer recurrent Macular telangiectasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Age-related macular degeneration

  • Randomized Study of Intravitreal mk-8748 Compared with Aflibercept in Patients with Neovascular Age‑Related Macular Degeneration

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Aflibercept
    Estonia Germany Latvia Poland Spain

  • Study of Port Delivery System with ranibizumab given every 36 weeks in patients with neovascular age-related macular degeneration

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Age-related macular degeneration
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Ranibizumab
    Austria Czechia Denmark France Germany Greece +3

  • Study on Treating Neovascular Age-Related Macular Degeneration with Aflibercept, Ranibizumab, and Brolucizumab for Patients with Active Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Age-related macular degeneration
    Investigated Drugs:
    • BROLUCIZUMAB
    • Ranibizumab
    • Aflibercept
    Austria

  • Study of Pozelimab and Cemdisiran for Adults with Geographic Atrophy from Age-Related Macular Degeneration

    Recruiting

    3 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    • Age-related macular degeneration
    Investigated Drugs:
    • Cemdisiran
    • Pozelimab
    Austria France Germany Hungary Italy Poland +1

  • A Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Age-related macular degeneration
    Investigated Drugs:
    • Aflibercept
    • Fluorescein Sodium
    Austria Croatia Czechia Denmark France Hungary +4

  • Safety, tolerability and exploratory efficacy of PST-611 in patients with geographic atrophy secondary to age-related macular degeneration

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    • Age-related macular degeneration
    France
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!